Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome.

  title={Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome.},
  author={Piero Portincasa and Leonilde Bonfrate and Maria Lia Scribano and Anna Kohn and Nicola Caporaso and Davide Festi and Mariachiara Campanale and Teresa Antonella Di Rienzo and Maria Guarino and Martina Taddia and Maria Vittoria Fogli and Maria Grimaldi and Antonio Gasbarrini},
  journal={Journal of gastrointestinal and liver diseases : JGLD},
  volume={25 2},
BACKGROUND AND AIMS Irritable Bowel Syndrome (IBS) patients still require effective treatment. The anti-inflammatory property of curcumin and the antispasmodic and carminative effect of fennel suggests that combination of these nutraceutical compounds would be useful in functional bowel disorders including IBS. We assessed the efficacy and tolerability of a combination of curcumin and fennel essential oil (CU-FEO) in IBS symptoms relief. METHODS 121 patients with mild-to-moderate symptoms of… 

Figures and Tables from this paper

The effect of curcumin on symptoms and quality of life in patients with irritable bowel syndrome

In summary, curcumin is effective in reducing the IBS clinical symptoms and improving the patients’ quality of life and it also has a high safety profile.

Efficacy of bio-optimized extracts of turmeric and essential fennel oil on the quality of life in patients with irritable bowel syndrome

Results from this “real-life” study show that the combination of turmeric and essential fennel oil over two months improves both symptoms and QoL in IBS patients, suggesting a potential role for the natural treatment of IBS.

Effects of propolis supplementation on irritable bowel syndrome with constipation (IBS‐C) and mixed (IBS‐M) stool pattern: A randomized, double‐blind clinical trial

The results showed that propolis supplementation might have a beneficial effect on constipation subtype of IBS (IBS‐C) and mixed subtype on IBS‐M severity by reducing the severity and frequency of abdominal pain in patients with irritable bowel syndrome.

Comparing the Efficacy of Cumin Sofouf With Mebeverine on Irritable Bowel Syndrome Severity and Quality of Life: A Double-blind Randomized Clinical Trial

  • Medicine
  • 2020
The present study aimed to assess the efficacy of a recommended drug from Persian medicine (Cumin Sofouf) on the score of IBS symptom severity and the quality of life as a clinical trial compared with mebeverine, which is a commonly used antispasmodic drug for this disorder.

A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS)

A Random-effects meta-analysis based on three studies and 326 patients found curcumin to have a beneficial albeit not statistically significant effect on IBS symptoms, but current findings are based on a considerably limited evidence base with marked heterogeneity.

Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review

It is concluded that polyphenols might be applicable for preventing IBS and improving the IBS symptoms, mainly through suppressing the inflammatory signaling pathways, which nowadays are known as novel platform for theIBS management.

Irritable bowel syndrome and diet

This paper will focus on available dietary interventions for IBS and will review the evidence for nutrition-based therapies and new therapeutic agents, namely nutraceutics, which are also an interesting option in the management of IBS patients.

Curcumin as an Aid to Improve Symptoms of Inflammatory or Irritable Bowel Diseases

There is not enough current evidence to conclude that curcumin alone can induce or maintain remission in IBD patients; with the current available data it appears that there may be symptomatic relief along with negligible risk for patients looking outside of standard maintenance therapies.

Potential Benefit with Complementary and Alternative Medicine in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.




Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study.

Turmeric may help reduce IBS symptomology and there was a favorable shift in self-reported bowel pattern, and placebo controlled trials are now warranted to confirm these findings.

Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Among patients who had IBS without constipation, treatment with rifaximin for 2 weeks provided significant relief of IBS symptoms, bloating, abdominal pain, and loose or watery stools.

Herbal medicines for treatment of irritable bowel syndrome.

Some herbal medicines may improve the symptoms of irritable bowel syndrome, however, positive findings from less rigorous trials should be interpreted with caution due to inadequate methodology, small sample sizes, and lack of confirming data.

A systematic review of alternative therapies in the irritable bowel syndrome.

A variety of treatments that exist beyond the scope of commonly used therapies for irritable bowel syndrome are explored, and Guarded optimism exists for traditional Chinese medicine and psychological therapies, but further well-designed trials are needed.

Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

  • H. HanaiT. Iida Y. Koide
  • Medicine, Psychology
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2006

Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid‐induced colitis

It is suggested that curcumin or diferuloylmethane, a major component of the food flavour turmeric, exerts beneficial effects in experimental colitis and may, therefore, be useful in the treatment of IBD.

Quality of Life in Persons with Irritable Bowel Syndrome (Development and Validation of a New Measure)

This quality-of-life measure specific to irritable bowel syndrome meets established psychometric criteria for reliability and validity; testing of its responsiveness is warranted.

Placebo effect in patients with irritable bowel syndrome

Emerging literature using functional brain imaging has started to document the neuronal changes associated with the placebo phenomenon in IBS patients, showing aberrant neural network during visceral placebo analgesia when compared to controls.

Curcumin: the potential for efficacy in gastrointestinal diseases.